A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer
NCT06343181 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2024-04-02
Summary
Qualitative observational study with the aim to explore medication adherence in a sample of patients with metastatic breast cancer.
Patients with metastatic breast cancer receiving or having received oral oncologic therapy, and attending the Division of Medical Senology at the European Institute of Oncology, will be included and enrolled in this research project."
Conditions
Sponsors & Collaborators
-
European Institute of Oncology
lead OTHER
Principal Investigators
-
Gabriella Pravettoni · European Institute of Oncology
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-03
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- Italy
Study Locations
More Related Trials
-
PrefeRences And ChemoTherapy In Breast Cancer patiEnts
NCT06332976 ·Status: RECRUITING
-
Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
NCT06800612 ·Status: RECRUITING
-
A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1
NCT00306631 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer
NCT02684032 ·Status: COMPLETED ·Phase: PHASE1
-
Abiraterone Acetate in Molecular Apocrine Breast Cancer
NCT01842321 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Neoadjuvant Chemoradiation on Pathologic Complete Response Rates in Locally Advanced Breast Cancer Patients
NCT06631066 ·Status: COMPLETED ·Phase: NA
-
Observational Study on the Treatment of Patients With Metastatic Breast Cancer
NCT06676436 ·Status: COMPLETED
-
Intraoperative Radiotherapy After Local Recurrence in Breast Cancer
NCT02386371 ·Status: COMPLETED ·Phase: NA
-
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
NCT03412643 ·Status: UNKNOWN ·Phase: PHASE2
-
Real wOrld studY in the Adjuvant Setting for High Risk earLy Breast Cancer Patients
NCT07151911 ·Status: RECRUITING
-
Metabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast Cancer
NCT07044791 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Implementing Patients´ Competence in Oral Breast Cancer Therapy
NCT04030728 ·Status: UNKNOWN
-
Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer
NCT01061359 ·Status: COMPLETED
-
Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer
NCT06650423 ·Status: RECRUITING
-
High Dose Chemotherapy and Autologous Transplant for Breast Cancer
NCT00186641 ·Status: UNKNOWN ·Phase: PHASE2
-
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
NCT02364557 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy
NCT00067314 ·Status: COMPLETED ·Phase: PHASE2
-
ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
NCT05662345 ·Status: ACTIVE_NOT_RECRUITING
-
Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility
NCT00617370 ·Status: COMPLETED ·Phase: NA
-
Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer
NCT06390241 ·Status: TERMINATED ·Phase: PHASE1
-
Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients
NCT00432172 ·Status: COMPLETED ·Phase: PHASE2
-
Human Epidermal Growth Factor Receptor 2 (HER2) Positive Unresectable Locally Advanced or Metastatic Breast Cancer Disease Registry Study
NCT02393924 ·Status: COMPLETED
-
Patterns of Relapse After Neoadjuvant Chemotherapy in Breast Cancer
NCT06210347 ·Status: NOT_YET_RECRUITING
-
Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer
NCT00003012 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Docetaxel in Breast Cancer Patients
NCT00174707 ·Status: COMPLETED ·Phase: PHASE3